Brandon Smith is a partner at Childers, Schlueter & Smith (CSS) in Atlanta, Georgia. He represents individuals nationwide in pharmaceutical litigation, mass torts, product liability, and serious personal injury cases.
With the first of two Vioxx trials to start on June 21, 2006, Merck & Co. has filed a motion for summary judgment on the case of a 73 year-old man who had a heart attack after taking Vioxx. The basis of the motion is that the lawsuit was filed after the statute of limitations had ran in California.
The Centers for Disease Control and Prevention has noted that nearly two-thirds of contact lens wearers who contracted eye infections reported using Bausch & Lomb’s ReNu with Mositureloc. The number of confirmed cases of fungal infection or Fusarium keratitis, has increased to dramatically in recent
Jose Guadalupe Ramirez, 25, and Raul De la Paz, 23, died after Ramirez tried passing several other vehicles in a no passing lane last week according to police. Speed was also said to be a contributing factor in the accident as Ramirez’ vehicle left Macland Road in Cobb County and slammed into a near
A jury panel of 5 women and 5 men has been selected in the latest trial asserted against Vioxx in Atlantic City, New Jersey. In this trial, the drug manufacture Merck & Co. is defending its pain mediation against the allegations of Elaine Doherty, a 68-year-old grandmother who suffered a heart attac
According to a new study published in the British Medical Journal, those who take Ibuprofen in high doses for long periods of time more than double the chances of having a heart attack when compared to those who use the drug less often. The common painkiller, which is available over the counter with
Wyeth, the manufacture of the notorious diet drug “Fen-Phen”, recently got final judicial approval to set up a legal settlement fund for the remaining consumers who were adversely affected by its use. The drug caused heart valve damage and primary pulmonary hypertension (PPH) from users of the drug
Boston Scientific Corporation recently issued another warning to physicians about another 996 defibrillators that may malfunction and leave its patients without sufficient protection from sudden cardiac death. The defect stems from a faulty low voltage capacitor which has been confirmed in over 30 d
Bausch & Lomb has decided to permanently remove ReNu with MoistureLoc off the worldwide market after an internal investigation showed this product increased the risk of Fusarium infection. The FDA has stated it supports this decision given the data they have analyzed and studied.According to the FDA
Canadian researchers recently discovered there is an increased risk of heart attack and other heart related problems when using Merck and Co.’s pain reliever Vioxx during the first two weeks. Previously, other studies emphasized the increased risks of heart related problems stemming from Vioxx after
Lowell Larson filed suit against Dr. Jeffery R. Weis and Northern Reflective Surgery Center of Hermantown after alleging they failed to warn him of the risks associated with LASIK surgery and caused “significant and permanent disturbances to his vision”. The eight person jury selected in the case ag
Bausch and Lomb has stopped shipments of its ReNu contact lens solution after the FDA and the Centers for Disease Control (CDC) linked it to a fungal eye infection that can cause temporary blindness. The CDC is currently investigating 109 reports of fusarium keratitis which can scar the cornea and b
The FDA recently updated safety labels on numerous drugs including Daypro, Motrin, Aleve, Carbatrol, and Midol among many others. These safety label changes are reflected in the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, or ADVERSE REACTIONS sections. The FDA suggests that any consumer
